Risk of seeding is reduced by associating diagnostic biopsy with percutaneous ablation for hepatocellular carcinoma

Gut

Volumn 58, Issue 5, 2009, Pages 734-735

  Germani, G ^a   Pleguezuelo, M ^a   Stigliano, R ^a   Burroughs, A K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOCUMENTATION; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; LIVER TRANSPLANTATION; NEEDLE TRACT SEEDING; PALLIATIVE THERAPY; PERCUTANEOUS BIOPSY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; LIVER TUMOR; METASTASIS; NEEDLE BIOPSY; NOTE; PATHOLOGY; TUMOR SEEDING;

BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NEOPLASM SEEDING;

EID: 66349101374     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.167650     Document Type: Letter

References (3)

1. Stigliano R, Marelli L, Yu D, et al. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007:33:437-47.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005:42:1208-36.
3. Stigliano R, Burroughs AK. Should we biopsy each liver mass suspicious for HCC before liver transplantation? - no, please don't. J Hepatol 2005:43:563-8.